메뉴 건너뛰기
Invasion and Metastasis
Volumn 18, Issue 5-6, 1998, Pages 252-260
Maximum effect of urokinase plasminogen activator inhibitors in the control of invasion and metastasis of rat mammary cancer
Author keywords

Amiloride; B428; Metastatic cancer; uPA inhibitors
Indexed keywords

AMILORIDE; B428; PLASMINOGEN ACTIVATOR INHIBITOR; UNCLASSIFIED DRUG; UROKINASE;
EID: 0032470280     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: 10.1159/000024518     Document Type: Article
Times cited : (15)
References (18)
  • 1
    • 0029009388 scopus 로고
    • Suppression of pulmonary metastasis of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor
    • Evans DM, Lin PL: Suppression of pulmonary metastasis of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor. Am Surg 1995;8:692-697.
    • (1995) Am Surg , vol.8 , pp. 692-697
    • Evans, D.M.1    Lin, P.L.2
  • 2
    • 0031802807 scopus 로고    scopus 로고
    • Time and dose dependency of pulmonary metastases of rat mammary cancer by amiloride
    • Evans DM, Sloan-Stakleff KD, Arvan M, Guyton DP: Time and dose dependency of pulmonary metastases of rat mammary cancer by amiloride. Clin Exp Metastasis 1998; 16:353-357.
    • (1998) Clin Exp Metastasis , vol.16 , pp. 353-357
    • Evans, D.M.1    Sloan-Stakleff, K.D.2    Arvan, M.3    Guyton, D.P.4
  • 3
    • 0029642314 scopus 로고
    • Prevention of prostate cancer metastases in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA)
    • Rabbani SA, Harakadis P, Davidson DJ, Henkin J, Mazar AP: Prevention of prostate cancer metastases in vivo by a novel synthetic inhibitor of urokinase-type plasminogen activator (uPA). Int J Cancer 1995;63:840-845.
    • (1995) Int J Cancer , vol.63 , pp. 840-845
    • Rabbani, S.A.1    Harakadis, P.2    Davidson, D.J.3    Henkin, J.4    Mazar, A.P.5
  • 4
    • 0021042282 scopus 로고
    • Plasminogen activators as markers of tumor colonization potential
    • Ng R, Kellen JA, Wong CHW: Plasminogen activators as markers of tumor colonization potential. Invasion Metastasis 1983;3:243-248.
    • (1983) Invasion Metastasis , vol.3 , pp. 243-248
    • Ng, R.1    Kellen, J.A.2    Wong, C.H.W.3
  • 5
    • 0026046509 scopus 로고
    • Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation
    • Quax PHA, Van Muijen GNP, Weening-Verhoeff EJD: Metastatic behavior of human melanoma cell lines in nude mice correlates with urokinase-type plasminogen activator, its type-1 inhibitor, and urokinase-mediated matrix degradation. J Cell Biol 1991;115:191-199.
    • (1991) J Cell Biol , vol.115 , pp. 191-199
    • Quax, P.H.A.1    Van Muijen, G.N.P.2    Weening-Verhoeff, E.J.D.3
  • 6
    • 0025908960 scopus 로고
    • Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer
    • Hollas W, Blasi F, Boyd D: Role of the urokinase receptor in facilitating extracellular matrix invasion by cultured colon cancer. Cancer Res 1991;51:3690-3695.
    • (1991) Cancer Res , vol.51 , pp. 3690-3695
    • Hollas, W.1    Blasi, F.2    Boyd, D.3
  • 7
    • 0023735157 scopus 로고
    • Urokinase plasminogen activator, a marker for aggressive breast carcinoma: A preliminary report
    • Duffy MJ, O'Grady P, Devancy D, O'Sorian L, Fennelly JJ, Lunen HJ: Urokinase plasminogen activator, a marker for aggressive breast carcinoma: A preliminary report. Cancer 1988;62:531-533.
    • (1988) Cancer , vol.62 , pp. 531-533
    • Duffy, M.J.1    O'Grady, P.2    Devancy, D.3    O'Sorian, L.4    Fennelly, J.J.5    Lunen, H.J.6
  • 8
    • 0021348003 scopus 로고
    • Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue
    • Kirchheimer J, Koller A, Binder BR: Isolation and characterization of plasminogen activators from hyperplastic and malignant prostate tissue. Biochim Biophys Acta 1984; 797:256-265.
    • (1984) Biochim Biophys Acta , vol.797 , pp. 256-265
    • Kirchheimer, J.1    Koller, A.2    Binder, B.R.3
  • 9
    • 0025995880 scopus 로고
    • Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type-1 inhibitor in breast cancer
    • Janicke F, Schmitt M, Graeff H: Clinical relevance of the urokinase-type and tissue-type plasminogen activators and of their type-1 inhibitor in breast cancer. Semin Thromb Hemost 1991;17:303-312.
    • (1991) Semin Thromb Hemost , vol.17 , pp. 303-312
    • Janicke, F.1    Schmitt, M.2    Graeff, H.3
  • 10
    • 0342677082 scopus 로고
    • Prognostic value of new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system
    • Heiss MM, Babic R, Allgayer H, Gruetzner U, Jauch KW, Loehrs U, Schildberg FW: Prognostic value of new functional risk factors in gastric cancer defined by the urokinase-type plasminogen activator system. Surg Forum 1992;43:482-485.
    • (1992) Surg Forum , vol.43 , pp. 482-485
    • Heiss, M.M.1    Babic, R.2    Allgayer, H.3    Gruetzner, U.4    Jauch, K.W.5    Loehrs, U.6    Schildberg, F.W.7
  • 11
    • 0027082979 scopus 로고
    • Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
    • Janicke F, Schmitt M, Pache L, Ulm K, Harbeck N, Hofler H, Graeff H: Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer. Breast Cancer Res Treat 1993;24:195-208.
    • (1993) Breast Cancer Res Treat , vol.24 , pp. 195-208
    • Janicke, F.1    Schmitt, M.2    Pache, L.3    Ulm, K.4    Harbeck, N.5    Hofler, H.6    Graeff, H.7
  • 12
    • 0029009388 scopus 로고
    • Suppression of pulmonary metastases of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor
    • Evans DM, Lin PL: Suppression of pulmonary metastases of rat mammary cancer by recombinant urokinase plasminogen activator inhibitor. Am Surg 1995;61:692-697.
    • (1995) Am Surg , vol.61 , pp. 692-697
    • Evans, D.M.1    Lin, P.L.2
  • 13
    • 0021045628 scopus 로고
    • Antibodies to plasminogen activator inhibit human tumor metastasis
    • Ossowski L, Reich E: Antibodies to plasminogen activator inhibit human tumor metastasis. Cell 1983; 35:611-619.
    • (1983) Cell , vol.35 , pp. 611-619
    • Ossowski, L.1    Reich, E.2
  • 15
    • 0027314501 scopus 로고
    • Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: An important new class of selective synthetic urokinase inhibitor
    • Towle MJ, Lee A, Maduakor EC, Schwartz CE, Bridges AJ, Littlefield 1 BA: Inhibition of urokinase by 4-substituted benzo[b]thiophene-2-carboxamidines: An important new class of selective synthetic urokinase inhibitor. Cancer Res 1993;53: 2553-2559.
    • (1993) Cancer Res , vol.53 , pp. 2553-2559
    • Towle, M.J.1    Lee, A.2    Maduakor, E.C.3    Schwartz, C.E.4    Bridges, A.J.5    Littlefield, B.A.6
  • 16
    • 0023926295 scopus 로고
    • Amiloride inhibits rat mucosal ornithine decarboxylase activity and DNA synthesis
    • Ulrich-Baker MG, Wang P, Fitzpatrick L, Johnson LR: Amiloride inhibits rat mucosal ornithine decarboxylase activity and DNA synthesis. Am J Physiol 1988;254:405-415.
    • (1988) Am J Physiol , vol.254 , pp. 405-415
    • Ulrich-Baker, M.G.1    Wang, P.2    Fitzpatrick, L.3    Johnson, L.R.4
  • 17
    • 0027569924 scopus 로고
    • Dual-attribute continuous monitoring of cell proliferation/cytotoxicity
    • Fields RD, Lancaster MV: Dual-attribute continuous monitoring of cell proliferation/cytotoxicity. Am Biotechnol Lab 1993;11:48-50.
    • (1993) Am Biotechnol Lab , vol.11 , pp. 48-50
    • Fields, R.D.1    Lancaster, M.V.2
  • 18
    • 0030957218 scopus 로고    scopus 로고
    • Activation mechanisms of matrix metalloproteases
    • Hideaki N: Activation mechanisms of matrix metalloproteases. Biol Chem 1997;378:151-160.
    • (1997) Biol Chem , vol.378 , pp. 151-160
    • Hideaki, N.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.